University of Pennsylvania School of Medicine Researchers Hot on the TRAIL of New Cancer Targets: Cell-Death Receptor Link Between Cancer Susceptibility and Inflammation

PHILADELPHIA - For over 10 years, Wafik S. El-Deiry, MD, PhD, Professor of Medicine, Genetics, and Pharmacology at the University of Pennsylvania School of Medicine, has been pursuing a cancer-targeting molecule called TRAIL and its molecular partners. TRAIL is normally produced by immune cells and curtails tumor spread by binding to a specialized receptor on a tumor’s surface.

MORE ON THIS TOPIC